NO971966L - Proteinkinase NPK-110 - Google Patents

Proteinkinase NPK-110

Info

Publication number
NO971966L
NO971966L NO971966A NO971966A NO971966L NO 971966 L NO971966 L NO 971966L NO 971966 A NO971966 A NO 971966A NO 971966 A NO971966 A NO 971966A NO 971966 L NO971966 L NO 971966L
Authority
NO
Norway
Prior art keywords
protein kinase
npk
alzheimer
maps
cancer
Prior art date
Application number
NO971966A
Other languages
English (en)
Other versions
NO971966D0 (no
Inventor
Eckhard Mandelkow
Eva-Maria Mandelkow
Jacek Biernat
Gerard Drewes
Original Assignee
Max Planck Gesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft filed Critical Max Planck Gesellschaft
Publication of NO971966D0 publication Critical patent/NO971966D0/no
Publication of NO971966L publication Critical patent/NO971966L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Neurology (AREA)
  • Biochemistry (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO971966A 1994-10-28 1997-04-28 Proteinkinase NPK-110 NO971966L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94117122 1994-10-28
PCT/EP1995/004258 WO1996013592A2 (en) 1994-10-28 1995-10-30 Protein kinase npk-110

Publications (2)

Publication Number Publication Date
NO971966D0 NO971966D0 (no) 1997-04-28
NO971966L true NO971966L (no) 1997-06-19

Family

ID=8216419

Family Applications (1)

Application Number Title Priority Date Filing Date
NO971966A NO971966L (no) 1994-10-28 1997-04-28 Proteinkinase NPK-110

Country Status (12)

Country Link
US (2) US6579691B1 (no)
EP (1) EP0791067B1 (no)
JP (1) JPH10508199A (no)
KR (1) KR100275591B1 (no)
CN (1) CN1168699A (no)
AT (1) ATE417930T1 (no)
CA (1) CA2203910A1 (no)
DE (1) DE69535901D1 (no)
HU (1) HUT77081A (no)
NO (1) NO971966L (no)
NZ (1) NZ295371A (no)
WO (1) WO1996013592A2 (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE438716T1 (de) * 1991-12-06 2009-08-15 Max Planck Gesellschaft Verwendung von protein-kinasen zur diagnose und behandlung der alzheimer-krankheit
AU6421498A (en) * 1997-04-28 1998-11-24 Helix Research Institute Serine/threonine protein kinase
WO2001081558A2 (en) * 2000-04-25 2001-11-01 Millennium Pharmaceuticals, Inc. 13295 novel protein kinase molecules and uses therefor
JP2005512501A (ja) * 2000-12-06 2005-05-12 インサイト・ゲノミックス・インコーポレイテッド キナーゼおよびホスファターゼ
US7119185B2 (en) * 2000-12-21 2006-10-10 Trustees Of The University Of Pennsylvania Hormonally up-regulated, neu-tumor-associated kinase
DE60226429D1 (de) * 2001-02-27 2008-06-19 Brni Neurosciences Inst Diagnose der alzheimer-krankheit auf basis von mitogenaktivierter proteinkinase-phosphorylierung
AU2002312241A1 (en) * 2001-06-05 2002-12-16 Exelixis, Inc. B3galts as modifiers of the p53 pathway and methods of use
US6492156B1 (en) * 2001-10-31 2002-12-10 Pe Corporation (Ny) Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
CA2527853A1 (en) * 2003-06-19 2005-01-13 Exelixis, Inc. Mptens as modifiers of the pten/igf pathway and methods of use
US8273536B2 (en) 2003-06-19 2012-09-25 Exelixis, Inc. Marks as modifers of the PTEN pathway and methods of use
CN100424184C (zh) * 2005-12-09 2008-10-08 浙江大学 疱疹类病毒基因芯片及其应用
US9433922B2 (en) * 2007-08-14 2016-09-06 Emd Millipore Corporation Media for membrane ion exchange chromatography based on polymeric primary amines, sorption device containing that media, and chromatography scheme and purification method using the same
KR101294725B1 (ko) * 2010-12-30 2013-08-08 연세대학교 산학협력단 인산화된 ｇｒａｓｐ를 포함하는 낭포성섬유증 치료용 약학 조성물
SG10201703771WA (en) 2011-09-19 2017-06-29 Axon Neuroscience Se Protein-based therapy and diagnosis of tau-mediated pathology in alzheimer's disease
CN117551674A (zh) * 2023-11-20 2024-02-13 内蒙古农业大学 沙葱萤叶甲微管亲和调节激酶GdMARK2基因的克隆及其功能

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0544942A1 (en) * 1991-12-06 1993-06-09 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Novel tools for the diagnosis and treatment of Alzheimer disease

Also Published As

Publication number Publication date
DE69535901D1 (de) 2009-01-29
CA2203910A1 (en) 1996-05-09
US7485712B2 (en) 2009-02-03
NZ295371A (en) 1998-11-25
NO971966D0 (no) 1997-04-28
WO1996013592A3 (en) 1996-08-01
AU3870295A (en) 1996-05-23
ATE417930T1 (de) 2009-01-15
US20040038361A1 (en) 2004-02-26
EP0791067B1 (en) 2008-12-17
AU714636B2 (en) 2000-01-06
JPH10508199A (ja) 1998-08-18
CN1168699A (zh) 1997-12-24
MX9703101A (es) 1998-07-31
HUT77081A (hu) 1998-03-02
US6579691B1 (en) 2003-06-17
US20030104516A1 (en) 2003-06-05
WO1996013592A2 (en) 1996-05-09
EP0791067A2 (en) 1997-08-27
KR100275591B1 (ko) 2001-02-01

Similar Documents

Publication Publication Date Title
ATE417930T1 (de) Proteinkinase npk-110
AU2001294541A1 (en) Mammalian genes; related reagents and methods
EP0683234A4 (en) ANTIBODIES DIRECTED AGAINST -g (b) -AMYLOID OR A DERIVATIVE THEREOF AND ITS USE.
EP0909814A3 (en) Use of protein kinases for the diagnosis and treatment of Alzheimer's disease
AR038568A1 (es) Anticuerpos anti-a beta y su uso
FI925986A0 (fi) Slumpartat bio-oligomer bibliotek, ett foerfarande foer syntetisering avdet samt ett foerfarande foer anvaendning av det
MX9709913A (es) Metaloconstrucciones determinadas estructuralmente y aplicaciones.
WO2002057259A3 (en) Pyrazole compounds useful as protein kinase inhibitors
DK1005540T3 (da) IKK-beta-proteiner, nukleinsyrer og fremgangsmåder
DE69435038D1 (de) Aktivin rezeptor-ähnliche kinase (alk), gehörend zur tgf rezeptorfamilie und/oder zur bmp rezeptorfamilie
EA200101037A1 (ru) Соединения и способы для лечения и диагностики рака легкого
WO2005000193A3 (en) Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases
MXPA02008239A (es) Gen humano de la esquizofrenia.
ATE212065T1 (de) Nukleinsäuremoleküle mit der fähigkeit zur unterscheidung von prpc und prpsc-prionprotein- isoformen und verfahren zu deren herstellung
WO2003028543A3 (en) Nucleic acid molecules, polypeptides and uses therefor, including diagnosis and treatment of alzheimer's disease
WO2002046767A3 (en) Diagnosis and treatment of alzheimer's disease
WO2001057219A3 (en) Mammalian interleukin-1-delta and -epsilon. their use in therapeutic and diagnostic methods
DE69728897D1 (de) Saeugetierchemokine
ATE266731T1 (de) Neue menschliche proteine, die cyclin abhängigen kinasen ähneln, sowie methoden zu deren verwendung
HUP0302566A2 (hu) Készítmények és eljárások emlőrák gyógykezelésére és diagnosztizálására
DE69621837D1 (de) Methoden zur feststellung von alzheimerscher krankheit
WO2001064876A3 (en) Human schizophrenia gene
EP0780472A3 (en) Stress proteins
WO2003060067A3 (en) P85-alpha nucleic acids, polypeptides and related methods
WO2002072626A3 (de) Neue form des phgpx-proteins als diagnostischer marker bei männlicher infertilität

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application